Compounds > cytarabine

cytarabine and Cancer of Esophagus

cytarabine has been researched along with Cancer of Esophagus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bi, Y; Cheng, X; Cui, H; Cui, Y; Gao, Y; Guo, M; Kong, P; Li, H; Liu, F; Ma, Y; Niu, X; Qian, Y; Wang, F; Xu, J; Yan, T; Yang, J; Zhang, L; Zhang, X1
Ajani, JA; Gould, P; Lynch, PM; Natrajan, G; Putnam, JB; Roth, JA; Roubein, LD; Ryan, MB; Walsh, G1
Kadono, A; Masuda, M; Misawa, S; Takino, T; Yamaguchi, N1
Batist, G; Boos, G; Mulder, D; Shennib, H; Thirlwell, M; Trudeau, M1
Akman, S; Carr, BI; Doroshow, J; Flanagan, B; Leong, L; Margolin, K; Odujinrin, O1
Goldenberg, DM; Schricker, KT; Sögtrop, HH; von der Emde, J1

Other Studies

6 other study(ies) available for cytarabine and Cancer of Esophagus

ArticleYear
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
    Theranostics, 2020, Volume: 10, Issue:24

    Topics: Aged; Animals; Carbohydrate Epimerases; Cell Line, Tumor; Cell Proliferation; Disease Progression; DNA Copy Number Variations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycosylation; Guanosine Diphosphate Fucose; Humans; Ketone Oxidoreductases; Lysosomal-Associated Membrane Protein 2; Male; Mice; Middle Aged; Prognosis; Receptor, ErbB-2; Whole Genome Sequencing; Xenograft Model Antitumor Assays

2020
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Premedication; Stomach Neoplasms; Survival Rate; Ultrasonography

1995
["MFC" therapy for advanced gastrointestinal cancer (author's transl)].
    Nihon Gan Chiryo Gakkai shi, 1975, Jun-20, Volume: 10, Issue:2

    Topics: Cytarabine; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Mitomycins; Pancreatic Neoplasms

1975
Neoadjuvant chemotherapy with cytosine arabinoside by continuous infusion and cisplatin for resectable squamous cell carcinoma of the esophagus.
    Journal of surgical oncology, 1992, Volume: 50, Issue:2

    Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cytarabine; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pilot Projects; Thrombocytopenia

1992
Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diamminedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tract.
    American journal of clinical oncology, 1989, Volume: 12, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cytarabine; Drug Evaluation; Drug Synergism; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged

1989
Peroral therapy with cytosine arabinoside. Preliminary laboratory and clinical findings.
    Arzneimittel-Forschung, 1968, Volume: 18, Issue:6

    Topics: Aged; Animals; Bone Marrow; Colonic Neoplasms; Cricetinae; Cytarabine; Esophageal Neoplasms; Humans; Leukemia L1210; Male; Middle Aged; Neoplasms, Experimental; Rectal Neoplasms; Stomach Neoplasms

1968